Brazil suspends dengue vaccine following two deaths

Brazilian health authorities have officially halted the administration of their dengue immunization program. This decision follows the emergence of two fatalities linked to the vaccine, prompting an immediate investigation into the safety of the treatment. Since the rollout began in 2026, over 500,000 individuals have been inoculated across the country. Officials are now conducting a thorough review of clinical data to determine if these deaths are directly attributable to the medication. Public health experts are working to reassure the population while monitoring those who have already received the shots. The suspension will remain in effect until a comprehensive safety assessment is completed.

The sudden pause of a major public health initiative involving hundreds of thousands of citizens highlights critical concerns regarding vaccine safety protocols and the urgency of managing a widespread tropical disease outbreak.